Akèy › Kansè pwostat › Kansas
Etid klinik pou Kansè pwostat nan Kansas
22 etid pou Kansè pwostat ap chèche patisipan nan sit nan Kansas.
Vil nan Kansas
- Kansas City12 etid
- Topeka7 etid
- Overland Park7 etid
- Olathe5 etid
- Lawrence3 etid
- Wichita3 etid
- Pittsburg3 etid
Tèks ofisyèl etid la (Anglè)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- ak 4 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT06931340Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Veteran Administration Eastern Kansas Healthcare, Leavenworth
- ak 4 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- University of Kansas Cancer Center, Kansas City
- The University of Kansas Cancer Center - Olathe, Olathe
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- ak 2 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- ak 4 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382DESTINY-PANTUMOUR04
- Research Site, Topeka
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- University of Kansas Hospital, Kansas City
Ap rekriteFaz 2/3
Laj 18 a 100 · Gason · Mizajou Sep 22, 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- University of Kansas Medical Center, Westwood
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 22, 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- University of Kansas Hospital, Kansas City
Ap rekriteFaz 3
Laj 18 a 100 · Gason · Mizajou Sep 22, 2026 · NCT06855277A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 15, 2026 · NCT07581184Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Wichita Urology Group, Wichita
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 11, 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- University of Kansas Cancer Center, Kansas City
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- ak 3 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05946213Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Kansas University Cancer Center, Kansas City
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 24, 2026 · NCT07745361Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- MidAmerica Cancer Care, Merriam
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Aug 21, 2026 · NCT04221542Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Central Care Cancer Center - Garden City, Garden City
- Mercy Hospital Pittsburg, Pittsburg
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Aug 19, 2026 · NCT04423211PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
- University of Kansas Medical Center, Kansas City
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Jul 22, 2026 · NCT06274047HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
- University of Kansas Health System, Kansas City
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT03802851Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Instititute - South, Overland Park
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699TERPS Trial for de Novo Oligometastic Prostate Cancer
- KU Medical Center- Cancer Center, Kansas City
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Jun 3, 2026 · NCT05223803Study of AZD0754 in Participants With Metastatic Prostate Cancer
- Research Site, Westwood
Ap rekriteFaz 1/2
Laj 18 a 130 · Gason · Mizajou Feb 23, 2026 · NCT06267729A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- Wichita Urology Group, Wichita
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Feb 4, 2026 · NCT04729114Vitamin D for Prostate Endocrine Therapy
- University of Kansas Cancer Center, Kansas City
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Health System Saint Francis Campus, Topeka
- ak 1 plis
Ap rekriteFaz 3
Laj 50 ak plis · Gason · Mizajou Jan 15, 2026 · NCT05838716Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- University of Kansas Cancer Center, Kansas City
- Olathe Health Cancer Center, Olathe
- University of Kansas Cancer Center-Overland Park, Overland Park
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 11, 2025 · NCT03678025Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.